Maher Albitar, Chief Medical Officer at NEOGENOMICS INC (NEO), sold 404,625 shares at $8.23 ($3.3M) on 2016-08-19, disclosed to the SEC on 2016-08-23.
Open-market sale of $3.3M NEO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.23 | 370,000 | $3.0M | 91.4% |
| 2 | $8.26 | 34,625 | $286K | 8.6% |
| Total | $8.23 avg | 404,625 | $3.3M | 100% |
| Filing → |
| NEO | SELL | 2016-09-13 | $988K | — | Filing → |
| NEO | BUY | 2014-03-31 | $51K | — | Filing → |